South Africa’s trans community hit by ‘serious’ shortage of ‘life-saving’ testosterone
South Africa’s trans and non-binary community is facing a worrying shortage of testosterone, leaving many at serious risk. The shortage is down to manufacturer Pfizer restricting its production of its Depo-Testosterone, a prescription hormone replacement therapy that helps many transmasc people, in favour of producing COVID-19 vaccines. Dr Anastacia Tomson told IOL that the current shortage is “serious” as the “communication from the company anticipates stock to be restored only in or after the second quarter of 2022”. As such, Dr Tomson warned that many trans, non-binary and gender non-conforming patients could be without the “essential and often life-saving” treatment potentially for months. She added that […]